Madrigal Pharmaceuticals advertising spend, FY2025

Madrigal Pharmaceuticals (MDGL) reported $145M of advertising expense for the fiscal year ended Dec 31, 2025. That is 15.1% of revenue of $958M. Up 175.3% from FY2024. Formerly Synta Pharmaceuticals.

Ad spend, FY2025
$145M
year ended Dec 31, 2025
Change vs prior year
+175.3%
vs FY2024
Share of revenue
15.1%
of $958M revenue
Rank by ad spend
#274
of 458 companies

Key facts

  • Ad spend is 2.8x its FY2024 level ($52.7M), slower than revenue (5.3x).
  • Madrigal Pharmaceuticals spends more on advertising than 40% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 3.3x the median of 4.5%.

Ad spend by fiscal year

$0 $50M $100M $150M FY2024 (ended 2024-12-31): $52.7M 2024 FY2025 (ended 2025-12-31): $145M 2025 $145M

Ad spend as % of revenue

0% 10% 20% 30% FY2024 (ended 2024-12-31): 29.3% 2024 FY2025 (ended 2025-12-31): 15.1% 2025 15.1%

Ad spend in context, FY2025

Advertising was 17.8% of selling, general and administrative expense. Research and development spending was 2.7x advertising. The company reported an operating loss of $300M.

Advertising $145M AdvertisingExpense
Selling, general and administrative $814M ad spend = 17.8%
Research and development $389M R&D = 2.7x ad spend
Operating loss -$300M
Net loss -$288M

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $145M +175.3% $958M 15.1% AdvertisingExpense 10-K Feb 19, 2026
FY2024 Dec 31, 2024 $52.7M n/a $180M 29.3% AdvertisingExpense 10-K Feb 19, 2026

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Madrigal Pharmaceuticals in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
272 loanDepot $147M 12.3% +10.6% FY2025
273 Yeti $145M 7.8% +2.8% FY2025
274 Madrigal Pharmaceuticals $145M 15.1% +175.3% FY2025
275 HubSpot $144M 4.6% +22.5% FY2025
276 Owens Corning $144M 1.4% +9.1% FY2025
277 BJ's Wholesale Club $143M 0.7% +13.0% FY2026
278 Autohome $143M 15.5% -22.4% FY2025

Full ranking of 458 companies · Biggest increases #4 · Ads above operating profit #87

Questions

How much does Madrigal Pharmaceuticals spend on advertising?

Madrigal Pharmaceuticals spent $145M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 19, 2026.

What percentage of revenue does Madrigal Pharmaceuticals spend on advertising?

15.1% of revenue in fiscal 2025 ($145M against $958M). The median across the 458 companies tracked is 4.5%.

Is Madrigal Pharmaceuticals spending more on advertising?

Yes. Ad spend rose 175.3% in fiscal 2025 from fiscal 2024.

How does Madrigal Pharmaceuticals rank by advertising spend?

#274 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does Madrigal Pharmaceuticals spend more on advertising than on R&D?

No. In fiscal 2025 it spent $389M on research and development and $145M on advertising.

What does Madrigal Pharmaceuticals's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 19, 2026
Accession number
0001628280-26-009514
Company
MADRIGAL PHARMACEUTICALS, INC., CIK 1157601, SIC 2834 (Pharmaceutical Preparations)
Former names
Synta Pharmaceuticals
Headquarters
West Conshohocken, PA
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq
SEC filer status
Large accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
Madrigal Pharmaceuticals advertising spend, FY2024-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 19, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/madrigal-pharmaceuticals/advertising-spend/
Download
CSV, all years · CSV, all 458 companies